Poland· PL-100447028
Nebilet HCT
A nebivolol und thiazide product containing nebivololum + hydrochlorothiazidum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Nebivolol und thiazide is registered in 9 of 19 countries.
Countries holding a registration under ATC C07BB12 (nebivolol und thiazide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Nebivolol und thiazide · ATC C07BB12
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Nebivololum + Hydrochlorothiazidum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- C07BB12
- ATC class
- Nebivolol und Thiazide
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991447489
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nebivolol und thiazide in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNEBILET PLUS HMenarini International Operations Luxembourg S.A., Luxembourg
- FranceCONEBILOX 5 mg/12,5 mg, comprimé pelliculéMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- ItalyALONEBMENARINI INTERNAT. O.L.S.A
- SpainLOBIVON PLUS 5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULAMenarini International Operations Luxembourg S.A.
- SwitzerlandNebilet plus 5/12,5 mg, FilmtablettenA. Menarini GmbH
- FinlandHypoloc CompMenarini International Operations Luxembourg S.A.
- GermanyNebivolol Comp. AbzRatiopharm Gmbh
- IrelandNebilet Plus 5 mg/12.5 mg film-coated tabletsMenarini International Operations Luxembourg S.A.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Nomexor Plus Hct
- Belgium · Nebivolol/Hct Eg, Nobiretic
- Bulgaria · Кардиостад Плюс, Небилет Плюс
- Cyprus · Lobivon-Plus
- Czechia · Nebilet Plus H
- Germany · Nebivolol Comp. Abz, Nebivolol Comp. Ratiopharm
- Denmark · Hypoloc Comp
- Estonia · Nebilet Plus
- Spain · Lobivon Plus, Silostar Plus
- Finland · Hypoloc Comp
- France · Conebilox, Nebivolol/Hydrochlorothiazide Biogaran
- Greece · Hypoloc-Plus, Lobivon-Plus
- Croatia · Nebilet Plus
- Hungary · Nebilet Plus
- Ireland · Nebilet Plus
- Italy · Aloneb, Lobidiur
- Lithuania · Nebilet Plus
- Luxembourg · Nobiretic
- Latvia · Nebilet Plus
- Malta · Nebilet Plus
- Netherlands · Hyporetic, Lobiretic
- Portugal · Nebilet Hct
- Romania · Co-Nebilet
- Slovenia · Co-Nebilet
- Slovakia · Nebilet Hctz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f9134c0b-d23b-414e-87ae-2246b3d91382 GET /v1/drugs/f9134c0b-d23b-414e-87ae-2246b3d91382?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "5 mg + 12,5 mg",
"packaging": "05909991447489 ¦ Rp ¦ 139134\n28 tabl.",
"substance": "Nebivololum 5 mg + Hydrochlorothiazidum 12.5 mg",
"common_name": "Nebivololum + Hydrochlorothiazidum",
"pl_product_id": "100447028",
"pozwolenie_nr": "35/21",
"auth_procedure": "IR",
"authorisation_validity": "2026-02-02"
}See everything about nebivolol und thiazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.